Literature DB >> 24335040

Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

Tamio Teramoto1, Jun Sasaki, Shun Ishibashi, Sadatoshi Birou, Hiroyuki Daida, Seitaro Dohi, Genshi Egusa, Takafumi Hiro, Kazuhiko Hirobe, Mami Iida, Shinji Kihara, Makoto Kinoshita, Chizuko Maruyama, Takao Ohta, Tomonori Okamura, Shizuya Yamashita, Masayuki Yokode, Koutaro Yokote.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24335040     DOI： 10.5551/jat.19349

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  8 in total

1.  Non-high-density cholesterol level as a predictor of maximum carotid intima-media thickness in Japanese subjects with type 2 diabetes: a comparison with low-density lipoprotein level.

Authors:  Yukihiro Bando; Hitomi Wakaguri; Keiko Aoki; Hideo Kanehara; Azusa Hisada; Kazuhiro Okafuji; Daisyu Toya; Nobuyoshi Tanaka
Journal:  Diabetol Int       Date:  2015-02-27

2.  Metabolic factors accelerate colorectal adenoma recurrence.

Authors:  Leo Taniguchi; Takuma Higurashi; Takashi Uchiyama; Yoshinobu Kondo; Eri Uchida; Shiori Uchiyama; Fumitake Jono; Jun Hamanaka; Hitoshi Kuriyama; Yasuo Hata; Hiroki Endo; Hirokazu Takahashi; Hajime Nagase; Nobuyuki Matsuhashi; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2014-10-23       Impact factor: 3.067

3.  Risk Factor of Cardiovascular Disease Among Older Individuals.

Authors:  Hiroshi Yatsuya; Masaaki Matsunaga; Yuanying Li; Atsuhiko Ota
Journal:  J Atheroscler Thromb       Date:  2016-10-26       Impact factor: 4.928

Review 4.  Pharmabiotics as an Emerging Medication for Metabolic Syndrome and Its Related Diseases.

Authors:  Thi Thanh Binh Nguyen; Yan Yan Jin; Hea-Jong Chung; Seong-Tschool Hong
Journal:  Molecules       Date:  2017-10-24       Impact factor: 4.411

5.  Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study.

Authors:  Rimei Nishimura; Haruka Kato; Koichi Kisanuki; Akinori Oh; Shinzo Hiroi; Yoshie Onishi; Florent Guelfucci; Yukio Shimasaki
Journal:  BMJ Open       Date:  2019-03-01       Impact factor: 2.692

6.  Current status of low-density lipoprotein cholesterol for primary prevention of coronary artery disease in late-stage elderly persons with type 2 diabetes mellitus: A retrospective, single-center study.

Authors:  Yuki Yamamoto; Jun Ito; Kei Ito; Masanao Fujii; Rikako Nakajima; Kazumi Saito; Hiroaki Yagyu
Journal:  J Diabetes Investig       Date:  2022-05-19       Impact factor: 3.681

7.  Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus.

Authors:  Shusuke Yagi; Ken-Ichi Aihara; Masashi Akaike; Daiju Fukuda; Hotimah Masdan Salim; Masayoshi Ishida; Tomomi Matsuura; Takayuki Ise; Koji Yamaguchi; Takashi Iwase; Hirotsugu Yamada; Takeshi Soeki; Tetsuzo Wakatsuki; Michio Shimabukuro; Toshio Matsumoto; Masataka Sata
Journal:  Diabetes Metab J       Date:  2015-07-21       Impact factor: 5.376

8.  N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.

Authors:  Kana Ide; Masaya Koshizaka; Hirotake Tokuyama; Takahiko Tokuyama; Takahiro Ishikawa; Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote
Journal:  Lipids Health Dis       Date:  2018-03-15       Impact factor: 3.876
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.